Search
Progyny Inc
PGNYAdd to Watchlist
26.250USD
+0.170+0.65%
Close 06/22, 16:00（ET）Quotes delayed by 15 min
2.05BMarket Cap
32.55P/E TTM
Earnings Forecast
Currency: USD Updated: 2026-06-22The current earnings forecast score of Progyny Inc is 8.55, ranking 12 out of 76 in the Healthcare Providers & Services industry. The average price target is 29.50, with a high of 33.00 and a low of 26.00.
Analyst Rating
Based on
11
analysts
Buy
Current Rating
29.727
Target Price
+13.98%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell
Peer Comparison
9
Total
22
Median
20
Average
Company name
Ratings
Analysts
Progyny Inc
PGNY
11
Unitedhealth Group Inc
UNH
30
Humana Inc
HUM
29
Elevance Health Inc
ELV
25
Cigna Group
CI
25
Centene Corp
CNC
22
1
2
Support & Resistance
Relevant data have not been disclosed by the company yet.
Financial Forecasting
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.
FAQs
What is Progyny Inc's expected revenue for the next quarter?
Progyny Inc's expected revenue is 348.65M.
What is Progyny Inc's price target?
Analysts forecast that Progyny Inc's price target is USD 29.50, with the highest forecast at USD 33.00 and the lowest forecast at USD 26.00.
How have Progyny IncPGNY's recent earnings per share performed?
The market expectation was USD 0.30, while Progyny IncPGNY's earnings per share (EPS) for the previous quarter was USD 0.15. EPS for the next quarter is expected at USD 0.33.
What is the analyst rating for Progyny Inc?
Based on the ratings of Progyny Inc's stock from 11 analysts, most analysts support a Buy trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as Buy. Please note that this is not trading advice. You still need to conduct your own analysis.
